Radiation therapy kills cancer cells by damaging their DNA so severely they can no longer divide and grow. But because the radiation passes through living tissue to reach a tumor, it also affects healthy cells along the way, producing side effects that range from skin redness to deep fatigue. What happens in your body during and after treatment depends on the dose, the location being treated, and how long the course lasts.
How Radiation Damages Cancer Cells
Ionizing radiation works by breaking the DNA inside cells. It can do this directly, snapping the double-stranded DNA helix apart, or indirectly, by generating unstable oxygen molecules that chemically attack DNA from the inside. Of all the types of damage radiation inflicts, double-strand DNA breaks are the most lethal to a cell. When both strands of the helix are severed at once, the cell’s repair machinery struggles to put the pieces back together accurately. If the damage is too extensive, the cell triggers its own death.
Cancer cells are particularly vulnerable to this because they divide rapidly and often have faulty DNA repair systems to begin with. Healthy cells, by contrast, are generally better at pausing their growth cycle, fixing sublethal damage, and resuming normal function. Research on human cell lines has shown that normal cells in a resting state can repair not only minor radiation damage but also potentially lethal damage, as long as they’re given time before being pushed to divide again. This biological difference is the entire basis for why radiation therapy works: it exploits the gap between how well healthy tissue recovers and how poorly cancer cells do.
Why Treatment Is Spread Over Weeks
Most curative radiation courses are divided into many small daily doses, typically delivered five days a week for several weeks. This approach, called fractionation, exists because of how cells recover between sessions. Each fraction delivers enough radiation to kill a portion of cancer cells while allowing nearby healthy tissue time to repair overnight. Cancer cells, with their broken repair machinery, accumulate damage faster than they can fix it. Over the full course, the tumor shrinks while surrounding tissue largely bounces back.
Total doses vary widely depending on the cancer type and treatment goal. Curative regimens for solid tumors commonly deliver 40 to 70 Gy (the unit used to measure absorbed radiation dose) over the full course. Palliative treatments, aimed at relieving symptoms rather than curing, use lower totals delivered in fewer sessions.
What Happens to Your Skin
Skin changes are one of the most visible and common effects of radiation, since the beam passes through the skin to reach deeper tissue. These changes follow a predictable, dose-dependent pattern. Within hours of the first few sessions, you may notice a faint, temporary flush that fades quickly. As the cumulative dose builds over weeks, more noticeable changes appear.
At cumulative doses around 6 to 10 Gy (often reached in the first week or two), mild redness and hair loss in the treatment area can develop. By 12 to 20 Gy, the redness becomes more defined and the skin may darken. Between 20 and 25 Gy, dry peeling begins, similar to a sunburn. At higher cumulative doses of 30 to 40 Gy, the peeling can become moist, especially in skin folds like the armpit or under the breast. Doses above 40 Gy carry a risk of open sores.
The National Cancer Institute grades these reactions on a four-point scale. Grade 1 is faint redness or dry flaking. Grade 2 involves brighter redness and moist peeling limited to creases. Grade 3 means moist peeling has spread beyond skin folds, with possible minor bleeding. Grade 4, which is rare with modern treatment planning, involves deep ulceration or tissue death. Most people experience grade 1 or 2 changes that heal within a few weeks of finishing treatment.
Why Radiation Makes You So Tired
Fatigue is the side effect that catches many people off guard. Even when radiation is aimed at a small area, like a breast or prostate, the exhaustion can feel whole-body and overwhelming. This isn’t just from the stress of daily hospital visits. There’s a measurable biological process behind it.
When radiation damages cells, your body launches an inflammatory repair response. Damaged tissue releases signaling molecules called proinflammatory cytokines, which are chemical messengers that recruit immune cells and coordinate healing. The problem is that these same molecules cross into the brain and directly trigger fatigue, much the way a bad flu makes you want to sleep for days. Research on breast and prostate cancer patients found that rising blood levels of specific inflammatory markers tracked closely with worsening fatigue during treatment. The higher the inflammatory signal, the more severe and prolonged the exhaustion.
This fatigue typically builds gradually over the course of treatment, often peaking in the final weeks. For most people it fades within a few weeks after the last session, though some experience lingering tiredness for months.
Effects on Internal Organs
When the treatment field includes or sits near the heart, lungs, or digestive tract, those organs can sustain collateral damage. Modern techniques minimize this exposure, but it can’t always be eliminated entirely.
Heart
Radiation to the chest, particularly for breast cancer, lung cancer, or lymphoma, can affect the heart in several ways. The damage starts at the cellular level: radiation generates unstable oxygen molecules that overwhelm the heart’s natural antioxidant defenses. This oxidative stress disrupts the energy-producing structures inside heart cells, triggering a chain reaction of inflammation and further damage. Blood vessels in the heart are especially sensitive. Radiation injures the inner lining of arteries, reducing their ability to produce the molecules that keep vessels relaxed and open. Over time, this leads to stiffening, narrowing, and scarring of the vessel walls. Even relatively low doses (as little as 8 Gy) can disrupt calcium signaling inside heart cells, promoting inflammation and increasing the risk of blood clots. The long-term consequences can include coronary artery disease, heart valve problems, irregular heart rhythms, and inflammation of the sac surrounding the heart.
Lungs
Lung tissue exposed to radiation can develop inflammation (pneumonitis) in the weeks to months following treatment, with symptoms like a dry cough, mild fever, and shortness of breath. If severe, this inflammation can transition into fibrosis, where normal, spongy lung tissue is gradually replaced by stiff scar tissue. The scarring thickens the walls between air sacs and collapses the spaces where oxygen exchange happens. Research has shown that oxidative damage in irradiated lung tissue doesn’t just happen once and stop. It increases progressively over the weeks and months after treatment, which explains why fibrosis can develop or worsen long after the last radiation session.
Digestive Tract
Radiation to the abdomen or pelvis commonly causes nausea, cramping, and diarrhea, typically appearing two to three weeks into treatment. The lining of the intestines replaces itself rapidly, making it especially sensitive to radiation. These symptoms usually resolve within a few weeks after treatment ends.
Acute Side Effects and Their Timeline
Most acute side effects appear within the first few weeks of treatment and involve tissues that naturally turn over quickly: skin, the lining of the mouth and throat, and the gut lining. For head and neck radiation, painful mouth sores and difficulty swallowing are common. For pelvic radiation, bladder irritation and bowel changes are typical. These reactions generally peak toward the end of treatment or shortly after, then begin healing within a few weeks as healthy cells repopulate the damaged areas.
The acute phase can also include loss of appetite and nausea, particularly when the treatment area is near the stomach or brain. Hair loss occurs only in the area being treated, not body-wide as with chemotherapy.
Late and Long-Term Changes
Some effects of radiation don’t appear for months or even years. These late effects result from slow, ongoing damage to tissue that was in the radiation field, and they tend to be permanent rather than temporary.
Fibrosis is the most common late complication. Irradiated skin and the tissue beneath it can gradually become firm, tight, and less flexible. This scarring process is chronic and progressive, meaning it can worsen over time rather than stabilize. Depending on the location, fibrosis can cause pain, limited range of motion, or contractures. Skin in the treated area may also show lasting changes: dryness, thinning, visible small blood vessels, permanent hair loss, and reduced or absent sweating.
There is also a small but real risk of developing a new, radiation-caused cancer in the treated area years later. A large study of prostate cancer patients found that the 15-year cumulative incidence of any secondary cancer was about 27% in those who received external beam radiation, compared to 22% in those treated with surgery alone. The excess risk was concentrated in organs directly in or near the radiation field, particularly the bladder and lungs. These secondary cancers typically have a latency period of at least five years, and the risk persists for well over a decade. The most common radiation-related skin cancers are squamous cell and basal cell carcinomas developing within old treatment fields.
How the Body Recovers
Your body’s recovery from radiation happens on two timelines. The acute effects, the skin irritation, fatigue, nausea, and soreness, mostly resolve within two to six weeks after the final session as rapidly dividing healthy cells replenish themselves. Most people notice a turning point roughly two to three weeks after treatment ends, when energy starts returning and skin begins to heal.
The slower recovery involves tissues that don’t regenerate as quickly, like connective tissue, blood vessels, and nerve fibers. Some of these changes stabilize over months, while others, particularly fibrosis, may be irreversible. The degree of long-term change depends heavily on the total dose received, the volume of tissue treated, and individual factors like age and whether chemotherapy was given alongside radiation.